Meetodi tõendite kirje

Phase II clinical trial

A Phase II clinical trial is the second stage in the drug or intervention development pipeline, conducted after Phase I safety testing. Its primary goal is to assess whether the intervention shows preliminary efficacy signals in a relevant patient population at the dose established in Phase I, while continuing to characterise the safety and tolerability profile. Phase II trials are generally smaller than Phase III confirmatory trials and serve as critical go/no-go decision points before large-scale investment.

Sources recorded, not reviewed

Allikakirje

Tsiteeringud kopeeritud meetodi allikakirjest sõna-sõnalt. Nendest ei saa järeldada väidete tasemel kinnitust.

Phase II Clinical Trial

Taksonoomiline meetodikirje · process-pipeline / epidemiology

Friedman, L. M., Furberg, C. D., DeMets, D. L., Reboussin, D. M., & Granger, C. B. (2015). Fundamentals of Clinical Trials (5th ed.). Springer. · ISBN 978-3319185392
Phase II clinical trial. Wikipedia. · URL

Ava täielik meetod

Kureeritud väited

Väited on salvestatud tõendite registrisse, igal oma hinnanguga.

Kureeritud väiteid veel pole

See vaade ei loo väite hinnangut, kui registris seda pole.

Seotud meetodid

Genereeritud meetodigraafist ja kuvatud masina soovitatud seostena – väiteid ei järeldata.

Taxonomic bucketAdaptive Randomized Clinical Trialmachine-suggested · Relational suggestion, not evidence.Same method familyDiagnostic Accuracy Study Designmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketDose-Response Analysismachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase I Clinical Trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketPhase III clinical trialmachine-suggested · Relational suggestion, not evidence.Taxonomic bucketRandomized clinical trialmachine-suggested · Relational suggestion, not evidence.